Lahesmaa-Rantala R, Magnusson K E, Granfors K, Leino R, Sundqvist T, Toivanen A
Department of Medical Microbiology, Turku University, Finland.
Ann Rheum Dis. 1991 Feb;50(2):91-4. doi: 10.1136/ard.50.2.91.
The passive intestinal permeability of patients with yersinia triggered reactive arthritis was studied using different sized polyethylene glycols (PEGs) contained in a mixture of PEG 400 and PEG 1000. The investigation was carried out at least one year after the onset of yersinia infection, and patients had neither acute gastrointestinal nor joint symptoms. The control groups included patients with uncomplicated yersiniosis as well as healthy subjects who were either HLA-B27 positive or negative. An altered intestinal barrier function to PEG molecules was detected in patients with a history of yersinia infection compared with healthy controls. No significant differences in the permeability were found between patients with or without reactive arthritis, nor was there any association of increased permeability with HLA-B27. The passive permeability of the intestinal mucosa to the larger molecules was increased for an unexpectedly long time after the acute yersinia infection, probably contributing to the perpetuation of joint symptoms in subjects susceptible to a chronic joint disease.
使用聚乙二醇400和聚乙二醇1000混合物中包含的不同大小的聚乙二醇(PEG),研究了耶尔森菌引发的反应性关节炎患者的肠道被动通透性。该研究在耶尔森菌感染发病至少一年后进行,患者既无急性胃肠道症状也无关节症状。对照组包括无并发症的耶尔森菌病患者以及HLA - B27阳性或阴性的健康受试者。与健康对照组相比,有耶尔森菌感染病史的患者检测到对PEG分子的肠道屏障功能改变。有或无反应性关节炎的患者之间在通透性方面未发现显著差异,通透性增加也与HLA - B27无关联。急性耶尔森菌感染后,肠道黏膜对较大分子的被动通透性在出乎意料的长时间内增加,这可能导致易患慢性关节疾病的受试者关节症状持续存在。